News & Media

All Resources
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
General Information
General Information
June 6, 2024
2024
2024

With New Validation Data, BillionToOne Boosts Commercial Prospects of Therapy Selection Assay

Learn More
General Information
June 6, 2024
2024
2024

With New Validation Data, BillionToOne Boosts Commercial Prospects of Therapy Selection Assay

Learn More
Media Coverage
Media Coverage
May 3, 2024
2024
2024

GenomeWeb- BillionToOne Pushing Forward in Cancer Diagnostics With First Data on Response Monitoring Test

Learn More
Media Coverage
May 3, 2024
2024
2024

GenomeWeb- BillionToOne Pushing Forward in Cancer Diagnostics With First Data on Response Monitoring Test

Learn More
Media Coverage
Media Coverage
May 3, 2024
2024
2024

BioWorld MedTech Interview- BillionToOne test reduces need for Rhogam in 40% of Rh-negative pregnancies

Learn More
Media Coverage
May 3, 2024
2024
2024

BioWorld MedTech Interview- BillionToOne test reduces need for Rhogam in 40% of Rh-negative pregnancies

Learn More
Press Releases
Press Releases
April 17, 2024
2024
2024

BILLIONTOONE MITIGATING RHOGAM(R) SHORTAGE WITH UNITY FETAL RhD™ NON-INVASIVE PRENATAL TEST

Learn More
Press Releases
April 17, 2024
2024
2024

BILLIONTOONE MITIGATING RHOGAM(R) SHORTAGE WITH UNITY FETAL RhD™ NON-INVASIVE PRENATAL TEST

Learn More
Media Coverage
Media Coverage
March 19, 2024
2024
2024

BillionToOne is recognized by Forbes as one of America's Best Startup Employers for 2024!

Learn More
Media Coverage
March 19, 2024
2024
2024

BillionToOne is recognized by Forbes as one of America's Best Startup Employers for 2024!

Learn More
Press Releases
Press Releases
February 21, 2024
2024
2024

BILLIONTOONE ANNOUNCES ROSS TAYLOR AS CHIEF FINANCIAL OFFICER

Learn More
Press Releases
February 21, 2024
2024
2024

BILLIONTOONE ANNOUNCES ROSS TAYLOR AS CHIEF FINANCIAL OFFICER

Learn More
Press Releases
Press Releases
January 2, 2024
2024
2024

BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Learn More
Press Releases
January 2, 2024
2024
2024

BillionToOne to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Learn More
Press Releases
Press Releases
December 12, 2023
2023
2023

BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and Newborn

Learn More
Press Releases
December 12, 2023
2023
2023

BillionToOne Announces Global Collaboration to Provide its UNITY Fetal Antigen™ Clinical Trial Assay in Johnson & Johnson Phase 3 Clinical Trial of Nipocalimab in Hemolytic Disease of the Fetus and Newborn

Learn More